Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis.

Hommes DW, Bura A, Mazzolai L, Büller HR, ten Cate JW.

Ann Intern Med. 1992 Feb 15;116(4):279-84.

PMID:
1531108
[PubMed - indexed for MEDLINE]
2.

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

Quinlan DJ, McQuillan A, Eikelboom JW.

Ann Intern Med. 2004 Feb 3;140(3):175-83.

PMID:
14757615
[PubMed - indexed for MEDLINE]
3.

Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.

de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ, Hart HC, Sixma JJ, Nieuwenhuis HK.

Ann Intern Med. 1995 Jul 1;123(1):1-9.

PMID:
7539233
[PubMed - indexed for MEDLINE]
4.

Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

Doyle DJ, Turpie AG, Hirsh J, Best C, Kinch D, Levine MN, Gent M.

Ann Intern Med. 1987 Oct;107(4):441-5.

PMID:
3307582
[PubMed - indexed for MEDLINE]
5.

Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.

Simonneau G, Charbonnier B, Decousus H, Planchon B, Ninet J, Sie P, Silsiguen M, Combe S.

Arch Intern Med. 1993 Jul 12;153(13):1541-6.

PMID:
8391792
[PubMed - indexed for MEDLINE]
6.

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

Hull RD, Raskob GE, Pineo GF, Green D, Trowbridge AA, Elliott CG, Lerner RG, Hall J, Sparling T, Brettell HR, et al.

N Engl J Med. 1992 Apr 9;326(15):975-82.

PMID:
1545850
[PubMed - indexed for MEDLINE]
Free Article
7.

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.

Prandoni P, Lensing AW, Büller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, ten Cate JW.

Lancet. 1992 Feb 22;339(8791):441-5.

PMID:
1346817
[PubMed - indexed for MEDLINE]
8.

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.

Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM.

Ann Intern Med. 1999 May 18;130(10):800-9.

PMID:
10366369
[PubMed - indexed for MEDLINE]
9.

Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty.

Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J.

Ann Intern Med. 1993 Dec 1;119(11):1105-12.

PMID:
8239230
[PubMed - indexed for MEDLINE]
10.

Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice.

Zidane M, Schram MT, Planken EW, Molendijk WH, Rosendaal FR, van der Meer FJ, Huisman MV.

Arch Intern Med. 2000 Aug 14-28;160(15):2369-73.

PMID:
10927736
[PubMed - indexed for MEDLINE]
11.

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, Rosenbloom D, Sackett DL, Anderson C, Harrison L, et al.

N Engl J Med. 1986 Oct 30;315(18):1109-14.

PMID:
3531862
[PubMed - indexed for MEDLINE]
12.
13.

The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.

Hull RD, Pineo GF, Raskob GE.

Haemostasis. 1998;28 Suppl 3:8-16.

PMID:
10069757
[PubMed - indexed for MEDLINE]
14.

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K; Enoxaparin Clinical Trial Group.

Ann Intern Med. 2001 Feb 6;134(3):191-202.

PMID:
11177331
[PubMed - indexed for MEDLINE]
15.

Treatment of proximal deep-vein thrombosis using subcutaneously administered calcium heparin: comparison with intravenous sodium heparin.

White RH, Daschbach MM, McGahan JP, Keck K, Parsons GH, Hartling RP, Mungall D.

Haemostasis. 1992;22(3):129-37.

PMID:
1427457
[PubMed - indexed for MEDLINE]
16.

Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.

Lindmarker P, Holmström M, Granqvist S, Johnsson H, Lockner D.

Thromb Haemost. 1994 Aug;72(2):186-90.

PMID:
7831649
[PubMed - indexed for MEDLINE]
17.

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.

Lensing AW, Prins MH, Davidson BL, Hirsh J.

Arch Intern Med. 1995 Mar 27;155(6):601-7.

PMID:
7887755
[PubMed - indexed for MEDLINE]
18.

[Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review].

Lamy O, Cornuz J, Yersin B.

Schweiz Med Wochenschr. 1999 May 8;129(18):707-14. French.

PMID:
10407944
[PubMed - indexed for MEDLINE]
19.

Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.

Pini M, Pattachini C, Quintavalla R, Poli T, Megha A, Tagliaferri A, Manotti C, Dettori AG.

Thromb Haemost. 1990 Oct 22;64(2):222-6.

PMID:
2270531
[PubMed - indexed for MEDLINE]
20.

Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.

Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA.

Arch Intern Med. 1997 Dec 8-22;157(22):2562-8.

PMID:
9531224
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk